000 01487 a2200421 4500
005 20250515003153.0
264 0 _c20060711
008 200607s 0 0 eng d
022 _a0093-691X
024 7 _a10.1016/j.theriogenology.2005.08.017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBartolome, J A
245 0 0 _aThe use of a deslorelin implant (GnRH agonist) during the late embryonic period to reduce pregnancy loss.
_h[electronic resource]
260 _bTheriogenology
_cMay 2006
300 _a1443-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAbortion, Veterinary
_xepidemiology
650 0 4 _aAnimals
650 0 4 _aCattle
_xphysiology
650 0 4 _aCorpus Luteum
_xdrug effects
650 0 4 _aDrug Implants
650 0 4 _aFemale
650 0 4 _aFertility Agents, Female
_xadministration & dosage
650 0 4 _aOvarian Follicle
_xdrug effects
650 0 4 _aPregnancy
650 0 4 _aPregnancy, Animal
_xblood
650 0 4 _aProgesterone
_xblood
650 0 4 _aRandom Allocation
650 0 4 _aReproduction
_xdrug effects
650 0 4 _aTriptorelin Pamoate
_xadministration & dosage
700 1 _aKamimura, S
700 1 _aSilvestre, F
700 1 _aArteche, A C M
700 1 _aTrigg, T
700 1 _aThatcher, W W
773 0 _tTheriogenology
_gvol. 65
_gno. 8
_gp. 1443-53
856 4 0 _uhttps://doi.org/10.1016/j.theriogenology.2005.08.017
_zAvailable from publisher's website
999 _c15848138
_d15848138